Neostigmine Methylsulfate
Neostigmine Methylsulfate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Neostigmine Methylsulfate; Generic name: NEOSTIGMINE METHYLSULFATE; Manufacturer: Fresenius Kabi USA, LLC.
| Brand name | Neostigmine Methylsulfate |
|---|---|
| Generic name | NEOSTIGMINE METHYLSULFATE |
| Manufacturer | Fresenius Kabi USA, LLC |
| Used for | 1 INDICATIONS AND USAGE Neostigmine Methylsulfate Injection, a cholinesterase inhibitor, is indicated for reversal of the effects of nondepolarizing neuromuscular blocking agents (NMBA) after surgery. Neostigmine Methylsulfate, a cholinesterase inhibitor, is indicated for reversal of the effects of nondepolarizing neuromuscular blocking agents (NMBA) after surgery ( 1 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION Dosage Should be administered by trained healthcare providers ( 2.1 ) Recommend use of a peripheral nerve stimulator to determine whether neostigmine methylsulfate should be administered and to monitor recovery from neuromuscular blockade ( 2.1 ). Recommended dosage range is 0.03 mg/kg to 0.07mg/kg for reversing nondepolarizing neuromuscular block when administered with an anticholinergic agent (atropine or glycopyrrolate) ( 2.2 , 2.3 , 2.4 ) For reversal of NMBAs wit |
| Active ingredient(s) | NEOSTIGMINE METHYLSULFATE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=088f96eb-20b8-48f8-ac83-329f75a44ce1 |